Live Breaking News & Updates on Fung group holdings ltd

Stay updated with breaking news from Fung group holdings ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Forefront Analytics LLC Grows Stake in Athira Pharma, Inc. (NASDAQ:ATHA)

Forefront Analytics LLC grew its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA – Free Report) by 43.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,765 shares of the company’s stock after purchasing an additional 8,955 shares during the […] ....

Athira-pharma , Nan-fung-group-holdings-ltd , Athira-pharma-inc , Forefront-analytics , Exchange-commission , Advisor-group , Clarius-group , Laird-norton-trust-company , Nasdaq , Barclays-plc , Free-report , Norton-trust-company

Immatics (NASDAQ:IMTX) Hits New 52-Week High at $13.53

Immatics (NASDAQ:IMTX – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $13.53 and last traded at $13.41, with a volume of 499593 shares changing hands. The stock had previously closed at $12.42. Analyst Upgrades and Downgrades Separately, Mizuho boosted their target price […] ....

United-states , Jump-financial , Capital-management , Nan-fung-group-holdings-ltd , Exchange-traded-concepts , Get-free-report , Stock-down , Traded-concepts , Fung-group-holdings-ltd , Trexquant-investment , Immatics-daily

Athira Pharma, Inc. (NASDAQ:ATHA) Short Interest Down 12.1% in May

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a decrease of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily volume of 309,500 shares, […] ....

Athira-pharma , Nan-fung-group-holdings-ltd , Acadian-asset-management , Barclays-plc , Nasdaq , Athira-pharma-inc , Jacobs-levy-equity-management-inc , Perceptive-advisors , Athira-pharma-company-profile , Get-free-report , Asset-management , Levy-equity-management

Replimune Group, Inc. (NASDAQ:REPL) CEO Sells $130,655.18 in Stock

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns […] ....

Sushil-patel , Pricet-rowe-associates-inc , Replimune-group-company-profile , Securities-exchange-commission , Jacobs-levy-equity-management-inc , Replimune-group-inc , Institutional-investors-weigh-in-on-replimune-group , Nasdaq , Nan-fung-group-holdings-ltd , Acadian-asset-management , Clearbridge-investments , Replimune-group-trading

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Sees Significant Increase in Short Interest

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) saw a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 3,910,000 shares, an increase of 6.0% from the April 15th total of 3,690,000 shares. Based on an average daily volume of 1,550,000 shares, the days-to-cover ratio […] ....

Canada , Entrypoint , British-columbia , Piper-sandler , Erin-burkhart , Jean-jacques-bienaime , Morgan-stanley , Scotiabank , Citigroup , Avoro-capital-advisors , Nan-fung-group-holdings-ltd , Biomarin-pharmaceutical-inc